CytomX Therapeutics Inc (NASDAQ:CTMX)

7.53
Delayed Data
As of Jan 16
 -0.29 / -3.71%
Today’s Change
5.10
Today|||52-Week Range
19.75
-9.39%
Year-to-Date
No recent news for CytomX Therapeutics Inc.

Today’s Trading

Previous close7.82
Today’s open7.90
Day’s range7.50 - 7.98
Volume472,549
Average volume (3 months)489,744
Market cap$356.7M
Data as of 4:00pm ET, 01/16/2020

Growth & Valuation

Earnings growth (last year)-75.05%
Earnings growth (this year)+4.32%
Earnings growth (next 5 years)+0.62%
Revenue growth (last year)-16.92%
P/E ratioNM
Price/Sales10.57
Price/Book2.70

Competitors

 Today’s
change
Today’s
% change
INOInovio Pharmaceutica...+0.05+1.49%
PBYIPuma Biotechnology I...+0.54+6.40%
STMLStemline Therapeutic...+0.19+2.78%
NERVMinerva Neuroscience...+0.97+12.05%
Data as of 4:00pm ET, 01/16/2020

Financials

Next reporting dateMarch 5, 2020
EPS forecast (this quarter)-$0.47
Annual revenue (last year)$59.5M
Annual profit (last year)-$84.6M
Net profit margin-142.19%

Profile

Sector
Health Technology
Industry
Biotechnology
No executives to display
Corporate headquarters
South San Francisco, California

Forecasts